Market closedNon-fractional

Precigen/PGEN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Precigen

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Ticker

PGEN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Germantown, United States

Employees

202

Precigen Metrics

BasicAdvanced
$371M
Market cap
-
P/E ratio
-$0.39
EPS
1.88
Beta
-
Dividend rate
$371M
1.88
1.722
1.596
5.553
6.911
-615.45%
-29.84%
-68.94%
67.406
3.8
11.61
-5.363
-76.60%
-432.52%
-58.62%
-19.42%

What the Analysts think about Precigen

Analyst Ratings

Majority rating from 5 analysts.
Buy

Precigen Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2,370.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1M
-16.67%
Net income
-$24M
-28.18%
Profit margin
-2,370.00%
-13.82%

Precigen Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.16%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
-$0.08
-$0.13
-$0.10
-
Expected
-$0.10
-$0.08
-$0.08
-$0.09
-$0.09
Surprise
-20.00%
2.56%
67.74%
14.16%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Precigen stock?

Precigen (PGEN) has a market cap of $371M as of July 06, 2024.

What is the P/E ratio for Precigen stock?

The price to earnings (P/E) ratio for Precigen (PGEN) stock is 0 as of July 06, 2024.

Does Precigen stock pay dividends?

No, Precigen (PGEN) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Precigen dividend payment date?

Precigen (PGEN) stock does not pay dividends to its shareholders.

What is the beta indicator for Precigen?

Precigen (PGEN) has a beta rating of 1.88. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Precigen stock

Buy or sell Precigen stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing